167 related articles for article (PubMed ID: 24403239)
41. First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp.
Wyche TP; Hou Y; Braun D; Cohen HC; Xiong MP; Bugni TS
J Org Chem; 2011 Aug; 76(16):6542-7. PubMed ID: 21736356
[TBL] [Abstract][Full Text] [Related]
42. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
[TBL] [Abstract][Full Text] [Related]
43. EF24 (a Curcumin Analog) and ZSTK474 Emphasize the Effect of Cabozantinib in Medullary Thyroid Cancer.
Bertazza L; Sensi F; Cavedon E; Watutantrige-Fernando S; Censi S; Manso J; Vianello F; Casal Ide E; Iacobone M; Pezzani R; Mian C; Barollo S
Endocrinology; 2018 Jun; 159(6):2348-2360. PubMed ID: 29688429
[TBL] [Abstract][Full Text] [Related]
44. FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.
Lu Z; Ren Y; Zhang M; Fan T; Wang Y; Zhao Q; Liu HM; Zhao W; Hou G
Biomed Pharmacother; 2018 Nov; 107():1370-1376. PubMed ID: 30257352
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of NDRG2 Increases Iodine Uptake and Inhibits Thyroid Carcinoma Cell Growth In Situ and In Vivo.
Yin A; Wang C; Sun J; Gao J; Tao L; Du X; Zhao H; Yang J; Li Y
Oncol Res; 2016 Jan; 23(1-2):43-51. PubMed ID: 26802650
[TBL] [Abstract][Full Text] [Related]
46. Andrographolide Inhibits Proliferation of Colon Cancer SW-480 Cells
Khan I; Mahfooz S; Saeed M; Ahmad I; Ansari IA
Anticancer Agents Med Chem; 2021; 21(4):487-497. PubMed ID: 32679024
[TBL] [Abstract][Full Text] [Related]
47. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
[TBL] [Abstract][Full Text] [Related]
48. The role of Cdk5 in neuroendocrine thyroid cancer.
Pozo K; Castro-Rivera E; Tan C; Plattner F; Schwach G; Siegl V; Meyer D; Guo A; Gundara J; Mettlach G; Richer E; Guevara JA; Ning L; Gupta A; Hao G; Tsai LH; Sun X; Antich P; Sidhu S; Robinson BG; Chen H; Nwariaku FE; Pfragner R; Richardson JA; Bibb JA
Cancer Cell; 2013 Oct; 24(4):499-511. PubMed ID: 24135281
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of a Novel Second-Generation Somatostatin-Dopamine Chimera (TBR-065) in Human Medullary Thyroid Cancer: A Preclinical Study.
Dicitore A; Cantone MC; Gaudenzi G; Saronni D; Carra S; Borghi MO; Albertelli M; Ferone D; Hofland LJ; Persani L; Vitale G
Neuroendocrinology; 2021; 111(10):937-950. PubMed ID: 33075795
[TBL] [Abstract][Full Text] [Related]
50. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
[TBL] [Abstract][Full Text] [Related]
51. Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines.
Vitale G; Dicitore A; Pepe D; Gentilini D; Grassi ES; Borghi MO; Gelmini G; Cantone MC; Gaudenzi G; Misso G; Di Blasio AM; Hofland LJ; Caraglia M; Persani L
Mol Oncol; 2017 Aug; 11(8):1007-1022. PubMed ID: 28453190
[TBL] [Abstract][Full Text] [Related]
52. Antiproliferative effects of γ-secretase inhibitor, a Notch signalling inhibitor, in multiple myeloma cells and its molecular mechanism of action.
Hu J; Zhu X; Lu Q
J Int Med Res; 2013 Aug; 41(4):1017-26. PubMed ID: 23839278
[TBL] [Abstract][Full Text] [Related]
53. Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth
Jang S; Janssen A; Aburjania Z; Robers MB; Harrison A; Dammalapati A; Cheng YQ; Chen H; Jaskula-Sztul R
Oncotarget; 2017 Sep; 8(41):70828-70840. PubMed ID: 29050323
[TBL] [Abstract][Full Text] [Related]
54. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
[TBL] [Abstract][Full Text] [Related]
55. Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice.
Starenki D; Singh NK; Jensen DR; Peterson FC; Park JI
Cancer Lett; 2013 Oct; 339(1):144-51. PubMed ID: 23856028
[TBL] [Abstract][Full Text] [Related]
56. Linc00324 promotes the progression of papillary thyroid cancer via regulating Notch signaling pathway.
Wan JF; Wan JY; Dong C; Li L
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6818-6824. PubMed ID: 32633374
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas.
Ramone T; Romei C; Ciampi R; Tacito A; Piaggi P; Torregrossa L; Ugolini C; Elisei R
Endocrine; 2019 Sep; 65(3):623-629. PubMed ID: 31278686
[TBL] [Abstract][Full Text] [Related]
58. Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma.
Zatelli MC; Tagliati F; Amodio V; Buratto M; Pelizzo M; Pansini G; Bondanelli M; Ambrosio MR; Degli Uberti EC
Anal Cell Pathol (Amst); 2010; 33(5):207-16. PubMed ID: 20978326
[TBL] [Abstract][Full Text] [Related]
59. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer.
Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
[TBL] [Abstract][Full Text] [Related]
60. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]